miR-375 |
Facilitates macrophage recruitment, M2-like phenotype and tumor progression |
[71] |
miR-23a/miR-27a/miR24-2 cluster |
Promote M1-like phenotype, inhibit M2-like phenotype in breast cancer |
[72] |
miR-340-5p |
Promotes M2 polarization in glioblastoma |
[73] |
miR-155, miR-125b-2 |
Macrophage re-programming to M1-like phenotype in pancreatic cancer |
[74] |
miR-29a-3p |
Promotes M2 polarization in OSCC |
[75] |
miR-222-3p |
Promotes M2-like phenotype in ovarian cancer |
[76] |
miR-940 |
Promotes M2 polarization in epithelial ovarian cell carcinoma |
[77] |
miR-203 |
Promotes M2 polarization and metastasis in CRC |
[78] |
miR-145 |
Promotes M2-like phenotype in CRC |
[79] |
miR-16 |
Promotes M1-like phenotype in breast cancer |
[80] |
miR-103a |
Increases M2 polarization in lung cancer |
[81] |
miR-21-3p, miR-181d-5p, miR-125b -5p |
Promote M2 polarization, cancer cell migration, proliferation in EOC |
[82] |
miR-301a-3p |
Enriches M2-like macrophages via modulating PTEN/PI3Kγ axis in pancreatic cancer |
[83] |
miR-132, miR-29b-1, miR-27a, miR-146a, miR-222 |
Higher expression of these miRNAs promote M2b-like phenotype |
[59,84] |
miR-let7a, miR-320a, miR-146a |
Promote M2-like phenotype |
[85,86,87] |
miR-142-3p |
Inhibit M2 polarization, reduces tumor growth in HCC |
[88,89] |
let-7c |
Inhibits M1 polarization and promote M2-like phenotype |
[90] |
miR-1246 |
Promote M2 polarization via modulating STAT3 and NF-κB axis. |
[88,91] |
let-7d-5p |
Promote M2-like phenotype |
[16] |
miR-451, miR-21 |
Influence macrophage polarization in glioblastoma |
[92] |
Extracellular miRNAs Secreted from Cancer Cells Regulating Cancer Progression or Chemoresistance
|
Function
|
Reference
|
miR-221, miR-222 |
Promote tamoxifen resistance in breast tumor cells |
[93] |
miR-1246 |
Imparts chemoresistance in ovarian cancer cells |
[94] |
miR-21 |
Induces chemoresistance in neuroblastoma, enhances miR-155 expression |
[95] |
miR-23a-3p |
Promotes tumor cell escape via impairing T-cell function |
[96] |
miR-204-5p |
Regulates cisplatin resistance in EOC |
[97] |
miR-let7a |
Creates an immunosuppressive environment by enhancing the expression of M2-like phenotype associated genes |
[85] |
miR-142-3p |
Induces malignant phenotype in oral carcinoma |
[98] |
miR-105 |
Promotes tumor progression and metastasis via degrading vascular endothelial barriers |
[99] |
miR-214 |
Promotes tumor growth via deregulating PTEN and impairing T-cell function in mouse model |
[100] |
miR-21, miR-29a |
Induces inflammatory response in NSCLC cells via activating NF-kB pathway |
[101] |
Extracellular miRNAs Derived from TAMs Regulating Cancer Progression or Chemoresistance
|
Function
|
Reference
|
miR-7 |
Inhibits metastasis in EOC via modulating EGFR/AKT/ERK1/2 axis |
[102] |
miR-365 |
Promotes gemcitabine chemoresistance in PDAC |
[103] |
miR-29a-3p, miR-21-5p |
Establish an immunosuppressive environment in EOC |
[104] |
miR-155-5p, miR-21-5p |
Increase migration and invasion of colon cancer cells via downregulating BRG 1 |
[105] |
miR-125a/b |
Negatively influence tumor cell division and stemness properties of HCC via targeting CD90 |
[106] |
miR-21 |
Induces chemoresistance in gastric cancer |
[107] |
miR-501-3p |
Progression of PDAC via modulating TGF-β |
[108] |
miR-223 |
Imparts cisplatin resistance in EOC |
[109] |
miRNAs Involved in Macrophage Differentiation and Maturation
|
Function
|
Reference
|
miR-155, miR-146a, miR-338, and miR-342 |
Facilitate the progression of HSCs differentiation process |
[66] |
miR-17-92 cluster: miR-18a, miR-17, miR-92a, miR-19a, miR-19b-1, miR-20a |
Inhibition of their expression by PU.1 promote HSCs differentiation |
[67] |
miR-146a, miR-126, miR-29a, miR-155, miR-130a, miR-125a/b, miR-338, miR-342, miR-21, miR-196b |
Mediate differentiation and maturation of HSCs by regulating expression of various target genes |
[61,63,64,66,69,110] |
miRNAs Regulating Recruitment of Macrophages at Tumor Site
|
Function
|
Reference
|
miR148b |
Inhibits TAM infiltration in tumor |
[111] |
miR-375 |
Induces TAM infiltration in breast cancer |
[71] |
miR-125b |
Reduces recruitment of macrophages at tumor site |
[112] |